The effectiveness of a tailored intervention program on return-to-work in unemployed sick-listed cancer patients and survivors: A randomized controlled trial.
- Conditions
- CancerMalignities10027656
- Registration Number
- NL-OMON39528
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 171
Patients and survivors are eligible to participate in this study, when they are between 18 and 60 years old, when they have a primary diagnosis of cancer and when this diagnosis is registered at UWV, as the main cause for their sick-leave. Furthermore, they must be registered at UWV as a social security safety netter without an employment contract; they must have applied for a sickness benefit and they must be at sick leave for at least 6 months up to 60 months. Patients will be included if they finished intensive cancer treatment at least 6 weeks prior to the start of this study (based on self-report by the patient), if their health status allows them to participate in the study (based on self-report by the patient) and if there are no comorbidities of such extent (e.g., severe psychological or physical conditions) that would interfere with participating in this study (based on report from the patient*s general practitioner). In case a patient is still undergoing intensive (cancer) treatment (chemotherapy, radiotherapy, surgery or another type of intensive curative treatment), he/she will be included at a minimum of 6 weeks after finishing these treatments. Patients who are scheduled to undergo such treatments within the next 6 months will also be held to this criterion.
Patients will be excluded in case of comorbidity of such kind that participating in the tailored intervention program is not possible, in case of serious psychiatric disorders, in case of pregnancy, in case of a lack of knowledge of the Dutch language and/or in case of a conflict with UWV regarding a (previous) sickness benefit claim or a long-term disability claim. Additionally, patients will be excluded if they are participating or signed up to be participating in a concurrent scientific study and/or re-integration/rehabilitation program.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure is duration until sustainable RTW after sick leave,<br /><br>calculated as the number of days between the first date of sick leave and the<br /><br>first day the participant returns to work. Any kind of paid work or work<br /><br>resumption with ongoing benefits will be qualified as a return to work.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Rate of return-to-work during follow-up, readiness to return to work, fatigue,<br /><br>psychological distress, general participation in society, coping, general<br /><br>health and health related quality of life. Other parameters are:<br /><br>socio-demographic factors, co-morbidity, questions regarding cancer diagnosis<br /><br>and treatment, work-related questions.</p><br>